• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)-An ENETS MEN1 task force questionnaire study.
 

Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)-An ENETS MEN1 task force questionnaire study.

Options
  • Details
  • Files
BORIS DOI
10.48620/77369
Publisher DOI
10.1111/jne.13468
PubMed ID
39587981
Description
Multiple Endocrine Neoplasia type 1 (MEN1) Clinical Practice Guidelines (2012) are predominantly based on expert opinion due to limited available evidence at the time, leaving room for interpretation and variation in practices. Evidence on the natural course of MEN1-related neuroendocrine tumours (NET) and the value of screening programs has increased and new imaging techniques have emerged. The aim of this study is to provide insight in the current practices of screening and surveillance for MEN1-related NETs in ENETS Centers of Excellence (CoEs). A clinical practice questionnaire was distributed among all 65 ENETS CoEs. Response rate was 91% (59/65). In 14% of CoEs <10 patients, in 50% 10-49, in 31% 50-100 and in 3 centres (5%) >100 patients with MEN1 are seen. Practices with regard to screening and surveillance of NETs were markedly heterogeneous. Differences between countries were noted in the use of gut hormones for biochemical screening and the choice for imaging modality for screening/surveillance of pancreatic NETs (PanNETs). Magnetic resonance imaging (MRI) is the preferred modality for screening and surveillance of PanNETs, whereas this is computed tomography (CT) for thoracic NETs. Practices regarding screening for thoracic NETs were more homogeneous among larger volume CoEs, with longer screening intervals. The majority of CoEs tailored the surveillance of small pancreatic and lung NETs to observed growth rate. 68% of CoEs advise patients with clinical MEN1 with negative genetic testing to undergo periodic screening like mutation-positive patients. In conclusion, there is still marked heterogeneity in practice, although there are also common trends. Differences were sometimes associated with volume or country, but often no association was found. This underscores the need for clear and evidence-based practice recommendations.
Date of Publication
2025-01
Publication Type
Article
Subject(s)
600 - Technology::610 - Medicine & health
Keyword(s)
multiple endocrine neoplasia type 1
•
neuroendocrine tumour
•
screening
•
surveillance
•
survey
Language(s)
en
Contributor(s)
Pieterman, Carolina R C
Grozinsky-Glasberg, Simona
O'Toole, Dermot
Howe, James R
Ambrosini, Valentina
Belli, Susana H
Andreassen, Mikkel
Begum, Nehara
Denecke, Timm
Faggiano, Antongiulio
Falconi, Massimo
Grey, Jo
Knigge, Ulrich P
Kolarova, Teodora
Niederle, Bruno
Nieveen van Dijkum, Els
Partelli, Stefano
Pascher, Andreas
Rindi, Guido
Ruszniewski, Philippe
Stättner, Stefan
Vandamme, Timon
Valle, Juan W
Vullierme, Marie-Pierre
Welin, Staffan
Perren, Aurelorcid-logo
Institute of Tissue Medicine and Pathology
Bartsch, Detlef K
Kaltsas, Gregory K
Valk, Gerlof D
Additional Credits
Institute of Tissue Medicine and Pathology
Series
Journal of Neuroendocrinology
Publisher
Wiley
ISSN
1365-2826
0953-8194
Access(Rights)
open.access
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: 9f4e9a [ 5.02. 18:48]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo